Cuxhaven, DE, November 2, 2026 – We are proud to announce that our manufacturing site in Cuxhaven, Germany, has received Good Manufacturing Practice (EU GMP) certification from the German authorities. The facility operates in accordance with article 1 (5) of Commission Implementing Regulation (EU) 2025/2091 for veterinary medicinal products, reinforcing our commitment to consistent quality […]
Nijmegen, NL, October 1, 2026 – We are pleased to welcome Panthera Smit as Key Account Manager Benelux and Nordic Countries starting 1 October 2026. With more than five years of experience in the international poultry sector, Panthera brings extensive expertise in broilers, turkeys, animal health, welfare and vaccination strategies. Her background combines veterinary consultancy and […]
Bergen, Norway, July 7, 2026 – Following the recent news on the regulatory approval for Vaxxon Yersinia vet from the Norwegian Medical Products Agency (NoMA) – we are thrilled to share that the NoMA has now granted the marketing authorization for Vaxxon® Yersinia vet. Vaxxon Yersinia vet is a novel oil-based inactivated injectable targeting Yersinia […]
Cuxhaven, DE, July 1, 2026 – We are pleased to welcome Christiane Hundehege as Senior Key Account Manager Poultry starting 1 July 2026. Christiane will be responsible for autogenous vaccines in poultry in Europe & International Zone. After completing her studies in veterinary medicine at the University of Veterinary Medicine Hannover, she gained extensive experience […]
Cuxhaven, DE, July 1, 2026 – Wir freuen uns, Tobias Kramer als Key Account Manager DACH-Region willkommen zu heißen. Tobias startet am 1. Juli 2026. In dieser Funktion wird Tobias der zentrale Ansprechpartner für Kunden in Deutschland, Österreich und der Schweiz für unser Avishield-Geflügelimpfstoffportfolio und unsere autogenen Impfstofflösungen sein. Mit seinem fundierten Hintergrund im Geflügelsektor […]
Bergen, Norway, June 25, 2026 – Vaxxinova is pleased to announce that Vaxxon Yersinia vet has been granted regulatory approval in Norway by the Norwegian Medical Products Agency (NOMA). Vaxxon Yersinia vet is an inactivated vaccine developed for Atlantic salmon targeting Yersinia ruckeri, the causative agent of Enteric Redmouth Disease (ERM) in salmonids, a bacterial […]
Nijmegen, NL, June 1, 2026 – We are pleased to welcome 𝗠𝗮𝗿𝗲𝗸 𝗥𝘆𝗺𝗮𝗻𝗼𝘄𝘀𝗸𝗶, 𝗗𝗩𝗠, to Vaxxinova! Effective 1st of June 2026, Marek joins as 𝗞𝗲𝘆 𝗔𝗰𝗰𝗼𝘂𝗻𝘁 𝗠𝗮𝗻𝗮𝗴𝗲𝗿, 𝗣𝗼𝘂𝗹𝘁𝗿𝘆 – 𝗣𝗼𝗹𝗮𝗻𝗱. He will be part of Guilhem Devillechabrolle’s European team, supporting customers across Poland. Marek brings more than 𝟮𝟬 𝘆𝗲𝗮𝗿𝘀 𝗼𝗳 𝗵𝗮𝗻𝗱𝘀‑𝗼𝗻 𝗲𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲 𝗶𝗻 𝗽𝗼𝘂𝗹𝘁𝗿𝘆 𝗵𝗲𝗮𝗹𝘁𝗵, […]
Nijmegen, NL, May 12, 2026 – On June 2-4, 2026, the city of Utrecht in the Netherlands will host the 25th edition of VIV Europe at the Jaarbeurs facilities. This year’s edition is titled ‘WORLD EXPO FROM FEED TO FOOD’. VIV Europe is the event for the animal and poultry husbandry. Professionals active in the […]
Nijmegen, NL, April 17, 2026 – From 6–9 May 2026, Poreč (Croatia) will host Poultry Days 2026 (Peradarski dani 2026). Organised by the Croatian Veterinary Institute and the Poultry Centre in Zagreb, the scientific symposium brings together poultry health professionals from across Europe for oral presentations and poster sessions. Vaxxinova is pleased to support Poultry […]
Nijmegen, NL, March 6, 2026 – In a recent article by S&P Global Animal Health, we share updates on our long-term growth strategy. A clear commitment to being closer to our customers and providing a broad portfolio of licensed and autogenous vaccines for poultry, aqua and livestock worldwide. Read the full post here: Vaxxinova to […]